Early Indicators of Chronic Rejection in Lung Transplant



Status:Completed
Conditions:Pulmonary
Therapuetic Areas:Pulmonary / Respiratory Diseases
Healthy:No
Age Range:18 - 65
Updated:4/2/2016
Start Date:March 2006
End Date:December 2013
Contact:Lourdes Norwick, BSN, RN
Email:lnorwick@medicine.bsd.uchicago.edu
Phone:773-834-8076

Use our guide to learn which trials are right for you!

Role of Inflammatory and Fibroproliferative Cytokines in the Pathogenesis of Bronchiolitis Obliterans Syndrome-OP in Lung Transplant Recipients.

The purpose of this research is to discover the different patterns of cytokine production in
patients who may develop Bronchiolitis Obliterans Syndrome-0p (BOS-0p) which means ongoing
rejection. This is an early indicator of chronic rejection in lung transplant recipients.
These cytokines can be detected in the bronchoalveolar (lung) and tissue samples of lung
transplant recipients.

Lung transplant recipients are routinely followed in clinic every three months after the
first year post-transplant. Spirometry with measurement of FEV1, FVC and FEF25-75 are
obtained at each visit. In addition, lung transplant recipients undergo surveillance
bronchoscopy at one, three, six, nine and twelve months. All bronchoscopy specimens that are
obtained for this study will be obtained during bronchoscopies that were scheduled per the
physician caring for the patient. An extra 90 cc of sterile solution will be instilled into
bronchus and two extra transbronchial biopsies will be performed in addition to the routine
bronchoscopic procedure. Routinely, 4-8 transbronchial biopsy samples are obtained from the
transplanted lung. Two specimens will be randomly selected for study and the rest will
undergo routine histopathologic study. The study biopsies will be set aside and processed.
The study visits for this research will occur at the same time as standard of care post
transplant visits. We will collect subject's history,demographic of subject's transplant
data,donor procurement information, physical exam information, pregnancy tests,blood test
and spirometry results from the visits mentioned above.

Inclusion Criteria:

- Lung transplant recipients between the ages of 18 and 65 years old

- All patients must be able to give written informed consent

Exclusion Criteria:

- Lung transplant recipients who are unable to undergo bronchoscopy

- Lung transplant recipients who are unable to give informed consent
We found this trial at
2
sites
5801 South Ellis Avenue
Chicago, Illinois 60637
 773.702.1234
University of Chicago One of the world's premier academic and research institutions, the University of...
?
mi
from
Chicago, IL
Click here to add this to my saved trials
5801 South Ellis Avenue
Chicago, Illinois 60637
 773.702.1234
University of Chicago One of the world's premier academic and research institutions, the University of...
?
mi
from
Chicago, IL
Click here to add this to my saved trials